Methazolamide NDC 68094-908

NDC codes

FDA NDC Directory

Product NDC (as listed)68094-908Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68094-0908Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68094-908-50	68094090850	100 TABLET in 1 BOTTLE (68094-908-50)Marketed from Nov 30, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methazolamide
Generic name (nonproprietary): methazolamide
Active ingredients: Methazolamide — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Precision Dose, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215615
Marketing start: Nov 30, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 68094-908_5dc8c6ca-5710-4369-b0ae-37666210f03bSPL ID 5dc8c6ca-5710-4369-b0ae-37666210f03bSPL set ID 1e0e81c7-a328-4034-a6b3-4c83e9ac3a3eRxCUI 197939, 197940UNII W733B0S9SD

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468094090850 followed by a unit qualifier and the quantity

Package 68094-0908-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 4, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methazolamide Tablets, USP is indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215615

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215615
Product	Strength	Form · route	Labeler	Product NDC
Methazolamide	Methazolamide 50 mg/1	TabletOral	Precision Dose, Inc.	68094-808